Roivant Sciences Insider Sold Shares Worth $4,141,662, According to a Recent SEC Filing-January 2024-www.financetom.com

Roivant Sciences Insider Sold Shares Worth $4,141,662, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Roivant Sciences Insider Sold Shares Worth $4,141,662, According to a Recent SEC Filing

Jan 2, 2025 12:17 AM

03:06 AM EST, 01/02/2025 (MT Newswires) -- Eric Venker, President & Chief Operating Officer, on December 27, 2024, sold 354,604 shares in Roivant Sciences ( ROIV ) for $4,141,662. Following the Form 4 filing with the SEC, Venker has control over a total of 740,976 shares of the company, with 740,976 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1635088/000114036124050723/xslF345X05/form4.xml

Previous page： Market Chatter: Procter & Gamble to Disclose Audit Details on Wood Pulp Suppliers Next page： Phillips 66 to Sell Gulf Coast Express Pipeline Stake for $865 Million

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Market Chatter: Procter & Gamble to Disclose Audit Details on Wood Pulp Suppliers

Dec 16, 2024

08:04 AM EST, 12/16/2024 (MT Newswires) -- Procter & Gamble ( PG ) promised a group of shareholders it would disclose more details on its audit practices for wood pulp suppliers, Reuters reported Monday, citing the investors. Certain shareholders have been pushing the company to source forest products more sustainably, the report said. The investors and P&G are next expected...

Phillips 66 to Sell Gulf Coast Express Pipeline Stake for $865 Million

Dec 16, 2024

08:09 AM EST, 12/16/2024 (MT Newswires) -- Phillips 66 (PSX) said Monday it agreed to sell DCP GCX Pipeline, which holds a 25% non-operated stake in the Gulf Coast Express Pipeline, to an ArcLight Capital Partners affiliate for pre-tax proceeds of $865 million in cash, subject to adjustments. The energy provider said the sale price represents a 10.6x multiple of...

Soligenix Begins Patient Enrollment for Phase 3 Study of Drug Candidate for Cutaneous T-Cell Lymphoma

Dec 16, 2024

08:05 AM EST, 12/16/2024 (MT Newswires) -- Soligenix ( SNGX ) said Monday it has begun patient enrollment for its phase 3 study of its experimental therapy, HyBryte, to treat cutaneous T-cell lymphoma or CTCL. The company said the study builds on previous phase 3 results and additional supportive research. ...

Whitecap Resources Says Q4, Full-Year Production to Beat Guidance

Dec 16, 2024

08:05 AM EST, 12/16/2024 (MT Newswires) -- Whitecap Resources ( SPGYF ) on Monday said fourth-quarter production is now forecast to average 175,500 boe/d (65% liquids), above its previous guidance of 170,000 boe/d. Full-year production is expected to average 174,000 boe/d, 5% above Whitecap's original guidance of 162,000 - 168,000 boe/d. The company's annual production per share growth in 2024...